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Abstract
Background: Addiction to nicotine gum has never been described in never smokers or in never
users of tobacco.
Methods: Internet questionnaire in 2004–2006 in a self-selected sample of 434 daily users of
nicotine gum. To assess dependence on nicotine gum, we used modified versions of the Nicotine
Dependence Syndrome Scale (NDSS), the Fagerström Test for Nicotine Dependence and the
Cigarette Dependence Scale.
Results: Five never smokers used the nicotine gum daily. They had been using the nicotine gum
for longer than the 429 ever smokers (median = 6 years vs 0.8 years, p = 0.004), and they had higher
NDSS-gum Tolerance scores (median = 0.73 vs = -1.0, p = 0.03), a difference of 1.5 standard
deviation units. Two never smokers had never used smokeless tobacco, both answered "extremely
true" to: "I use nicotine gums because I am addicted to them", both "fully agreed" with: "after a few
hours without chewing a nicotine gum, I feel an irresistible urge to chew one" and: "I am a prisoner
of nicotine gum".
Conclusion: This is to our knowledge the first report of addiction to nicotine gum in never users
of tobacco. However, this phenomenon is rare, and although the long-term effect of nicotine gum
is unknown, this product is significantly less harmful than tobacco.
Background
Nicotine replacement therapy (NRT) is effective to treat
tobacco dependence, and about one third of smokers ever
used NRT products [1-3]. In many countries, NRT prod-
ucts can be obtained on general sales, in drugstores or on
the internet, without a medical prescription and without
counselling [3]. NRT products are therefore easily accessi-
ble to nonusers of tobacco. Since nicotine has the poten-
tial to be addictive, there is a possibility that non-users of
tobacco may become addicted to NRT products. There is
to our knowledge, however, no published case of addic-
tion to NRT products in never smokers or in never users of
tobacco. Among former smokers who used the nicotine
gum to quit smoking, the prevalence of dependence on
the gum is very low, about one percent [4-6]. The propor-
tion of never-smokers and never-users of tobacco among
regular nicotine gum users is unknown and, contrary to
what many people believe, this proportion may not nec-
essarily be zero. The aim of this study was to assess
whether we could identify never-smokers and never-users
of tobacco who used the nicotine gum or were addicted to
it.
Methods
We posted a questionnaire on nicotine gum use on the
internet between September 2004 and March 2006, in
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English, on the smoking cessation website http://stop-
tabac.ch[7,8]. The questionnaire was listed second on
Google.co.uk when typing "nicotine gums" (tested
November 8, 2006).
A link to the questionnaire was posted on other smoking
cessation websites. The questionnaire is available at [9].
This study was not submitted to an ethics committee, but
participants were informed that their answers were stored
on file and had the option to refuse storage of their data.
Questions included: Have you ever used nicotine replace-
ment products (i.e. nicotine gums, patches, tablets or
inhalers)? (Yes, no); Do you currently use nicotine
replacement products? (Every day, occasionally, used in
the past, never used); Currently, on how many days per
week do you use nicotine chewing gums?; How long did
your current episode of nicotine gum use last?; Currently,
how many nicotine chewing gums do you use per day?
Questions also covered intention to stop using the gum,
serious attempts to stop using nicotine gum in the past
year, duration of the last attempt to stop using the gum
and urges to use nicotine gum during the last quit
attempt. We defined never smokers as people who
answered "No" to: "Have you ever smoked 100 cigarettes
or more in your lifetime?" and: "No, I never was a
smoker" to: "Do you currently smoke tobacco?". Use of
smokeless tobacco was assessed by email, in never smok-
ers who reported using nicotine gum daily in the online
questionnaire.
Because we know of no published, validated question-
naire measuring dependence on the nicotine gum, we
modified the Fagerström Test for Nicotine Dependence
(FTND), the Nicotine Dependence Syndrome Scale
(NDSS) and the Cigarette Dependence Scale (CDS) to
assess gum dependence [10-13]. FTND and CDS are uni-
dimensional, whereas NDSS covers 5 dimensions of
dependence: Drive, Priority, Tolerance, Continuity and
Stereotypy [11]. In all items, we replaced the words "ciga-
rette" by "nicotine gum", and "smoking" by "using" or
"chewing nicotine gum". We computed NDSS standard-
ized scores as recommended [11]. We dropped the NDSS
item: " Even if travelling a long distance, I'd rather not
travel by airplane because Iwouldn't be allowed to
smoke", because it cannot easily be modified for nicotine
gum use. We modified the NDSS item "I tend to avoid res-
taurants that don't allow smoking, even if I would other-
wise enjoy the food" to: "I tend to avoid places where I
cannot chew nicotine gum, even if I would otherwise
enjoy the company". We used Mann-Whitney U-tests to
compare medians and chi-square tests to compare propor-
tions.
Results
There were 848 participants in the online survey, includ-
ing 436 daily users of nicotine gum, 68 occasional (non-
daily) users and 344 non-users. Among the 434 daily gum
users who indicated their smoking status, there were 349
former smokers (80%), 80 current smokers (18%) and 5
never smokers (1.2%). The median age of these 5 never
smokers was 44 years (range 38 to 59 years), they com-
prised 3 women and one man (one missing answer), and
3 people who lived in the USA and one in the UK (one
missing answer).
Compared with the 429 ever smokers who used the gums
daily, the 5 never smokers tended to have higher nicotine
gum dependence scores for all FTND-gum, CDS-gum and
NDSS-gum scales, but statistically significant differences
were observed only for the NDSSgum Tolerance score
(never smokers: median = 0.73, ever smokers: median = -
1.0, Mann-Whitney U-test: p = 0.03), which represents a
difference of 1.5 standard deviation units. Three of the 4
never smokers who answered this NDSS question, but
only 14% of ever smokers answered "extremely true" to:
"compared to when I first started using nicotine gum, I
can use many, many more nicotine gum now before I start
to feel nauseated or ill" (chi-square = 13.2, p = 0.01). In
addition, the duration of the current episode of nicotine
gum use was longer in the 5 never smokers than in the 429
ever smokers (median = 6 years vs 0.8 years, Mann-Whit-
ney U-test: p = 0.004).
We obtained more information by e-mail from 4 of the 5
never smokers who used the nicotine gum daily. Three of
these 4 people confirmed that they had never smoked, but
one woman said she had smoked a few cigarettes occa-
sionally. Three said they had never used smokeless
tobacco, but one man said he had used small amounts of
tobacco snuff as a child, decades before he started using
the nicotine gum. They authorized us to report their com-
ments.
E., female, 38, USA, was using the nicotine gum for 2 years,
used 5 gums/day
"I've never smoked. My sister had some nicotine gum
when she was trying to quit smoking, and I happened to
try a piece. It seemed to wake me up and give me an energy
boost, which I liked. I don't drink coffee, so I use the gum
to wake me up when I'm feeling drowsy."
S., female, 39, USA, was using the nicotine gum for 10 years,
used 15 gums/day
"I have never smoked cigarettes. I started using nicotine
gum by chance, when a medical student offered them to
me to try. I still use them because I am addicted to nico-BMC Public Health 2007, 7:159 http://www.biomedcentral.com/1471-2458/7/159
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tine, and can not seem to quit using them even if have
tried."
In e-mail messages, these two participants (E. and S.)
answered that they had never used smokeless tobacco,
had never abused or been dependent on other substances
and had never been diagnosed with a psychiatric illness.
In the online questionnaire, these 2 never-users of
tobacco reported addiction levels to the gum of 95 and 98
on a scale of 0–100, FTND-gum ratings of 2 and 5, CDS-
gum ratings of 44 and 56 and NDSS-gum ratings of -0.9
and 0.42.
Both answered "extremely true" to: "I use nicotine gums
because I am addicted to them" and: "I use nicotine gum
because I a cannot stop using them" and: "I use nicotine
gum to deal with stress". Both reported that stopping
using all NRT products would be "very difficult". Both
"fully agreed" with: "after a few hours without chewing a
nicotine gum, I feel an irresistible urge to chew one", "I
am a prisoner of nicotine gum" and: "after chewing a nic-
otine gum, I am able to concentrate better". Both "seri-
ously considered" stopping NRT in the next 6 months.
One had made a serious attempt to stop using the gums
during the previous year, during which she felt a "very
strong" urge to use nicotine gum. This failed quit attempt
lasted 30 days.
In the online survey, three additional participants
reported being never smokers. Two of them could be fur-
ther contacted by e-mail:
G., female, 59, USA, was using the nicotine gum for 10 years,
used 10 gums/day
"During the time [my husband] was a smoker, I was a
"social smoker". I would smoke at parties [his cigarettes]
and occasionally at home after dinner or with a drink. I
never bought or carried cigarettes with me, I only smoked
his or on occasion my co-worker's. [...] About 15 years
ago, my husband [...] started chewing prescription
Nicorette, and I chewed it occasionally as well. When it
became available over the counter, we both just continued
to chew it, and I became more and more addicted to it. I
started with one or two pieces occasionally, then one or
two a day, and finally up to a dozen pieces a day, and con-
tinued at the rate for several years, maybe 4–5 years [...]. It
is really awful to be addicted to a substance, and I reached
a point where my throat hurt, my teeth hurt, I had a head-
ache most days, [...] but I still kept chewing. And it is so
expensive – I was spending over a $100 a month on it."
In an e-mail message, this participant (G.) said she had
never used smokeless tobacco and had never abused or
been addicted to other substances. She had been diag-
nosed with depression after a severe traumatic stress and
took antidepressants (paroxetine) for several years after
that. She said: "I think the depression was a natural reac-
tion to [the traumatic stress]. Nicotine was part of my self-
medication duringall this".
A., male, 49, UK, was using the nicotine gum for 6 years, used
20 gums/day
This participant reported that he had occasionally used
small quantities of tobacco snuff as a child, between the
age of 11 and 14, but not any more since then. He also
said he had suffered from depression and had been pre-
scribed fluoxetine by his family doctor. He reported:
"I have never smoked any tobacco product or even mari-
juana in my life. I have experimented with LSD, psilocy-
bin, amphetamines but not currently using any of these.
Several years ago, purely out of interest I bought a pack of
nicotine gum to see what the effect of nicotine would be.
I remember feeling quite ill [...]. It was about a year or so
later [...], I remembered my pack of nicotine gums and
started to use them maybe two or three times a day. I
didn't expect that I would ever become addicted [...].
Within a short period of time I was using 15 pieces per
day. Just as people say about smoking, I genuinely
enjoyed using the gum [...]. On several occasions I
stopped using it 'cold turkey'. The symptoms were mainly
light headedness and difficulty in concentration, most of
the time I just bought more gums – like a smoker [...].
Most of my life I have suffered from depression [...]. I
hadn't considered until then that nicotine could have
such a stabilising effect. I would very much like to quit.
The gum is very expensive [...]. Nicotine gum is a form of
self-medication [...]. I would argue that my state of mind
has become more calm and regulated since using nicotine
gums and reverts to previous, unsatisfactory state when I
stop using nicotine gums. [...] I started using the illicit
drugs above shortly before using nicotine gums on a reg-
ular basis."
These two participants (G. and A.) reported levels of
addiction to the gums of 80 and 95 on a 0–100 scale,
FTND-gum ratings of 5 and 6, CDS-gum ratings of 50 and
55 and NDSS-gum ratings of -0.21 and 0.67. Both
answered "extremely true" to: "I use nicotine gums
because I am addicted to them". Both had made a serious
attempt to stop using NRT in the previous year, but only
one reported more details about that quit attempt, which
lasted 60 days and was accompanied with "very strong"
urges to use nicotine gum. Both reported usually chewing
their first gum of the day 10 minutes after waking up, both
"fully agreed" with: "after a few hours without chewing a
nicotine gum, I feel an irresistible urge to chew one", "the
idea of not having any nicotine gum causes me stress",BMC Public Health 2007, 7:159 http://www.biomedcentral.com/1471-2458/7/159
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"sometimes I drop everything to go out and buy nicotine
gums", "chewing a nicotine gum calms me down when I
am stressed", and: "after chewing a nicotine gum, I am
able to concentrate better".
Discussion
In an online study of nicotine gum users, we identified 5
never smokers who used the nicotine gum daily. There
was reasonable evidence that most of these 5 never smok-
ers were addicted to the nicotine gum. Of particular inter-
est are the two cases of never users of tobacco (including
smokeless tobacco) who reported being addicted to the
nicotine gum. This is to our knowledge the first report of
such cases.
Surprisingly, these 5 never smokers had been using the
nicotine gum for many more years than ever smokers, and
they tended to be more dependent on the gum. For ciga-
rette dependence, FTND scores of 5 or more reflect a
strong dependence [14,15]. Four of the 5 never smokers
had FTND-gum scores of 5 or more, which suggests that
these people were strongly dependent on the gum. In a
previous study, the average CDS score in daily smokers
was 47, and daily smokers who had CDS scores >=50
smoked on average 25 cigarettes per day and smoked their
first cigarette within 10 minutes of waking up [13]. Three
of the 5 never smokers in the present study had CDS-gum
scores at or above 50, which suggest that they were
strongly dependent on the nicotine gum. Never smokers
had substantially higher NDSSgum Tolerance scores than
ever smokers, which may reflect that ever smokers were
already tolerant to nicotine before they started using the
gum.
Never-smokers reported classical criteria of dependence,
such as a compulsion to use the gum, use in higher dosage
and for a longer duration than initially intended, with-
drawal symptoms, unsuccessful attempts to stop and gum
use despite its high cost [16,17]. Their open-ended
answers also reflected classical criteria of dependence,
such as failed quit attempts followed by urges to use the
gum, relief of withdrawal symptoms (e.g. difficulty con-
centrating) by gum use, and withdrawal symptoms (e.g.
urges to use the gum after a few hours).
People who were addicted to the nicotine gum could eas-
ily find our questionnaire, because it was listed on top of
the list in Google. In spite of this effective enrolment strat-
egy, we identified only two never-users of tobacco among
daily gum users, which suggests that NRT use in never-
users of tobacco is a rare phenomenon. Similarly, a previ-
ous survey in people who responded to a newspaper ad
that read: "Are you addicted to nicotine gum?" could not
enrol any never smoker [5]. Furthermore, there was no
report of subsequent nicotine dependence in never smok-
ers who were treated with nicotine for ulcerative colitis,
aphtous ulcers and sleep-disordered breathing [18-21].
The short-tem effect of the nasal spray was also tested in
never smokers, with no report of never smokers getting
addicted to this fast delivery product [22-24]. In a previ-
ous survey, 0.3% of adolescent never smokers reported
past daily use of NRT, but none was reported as being
addicted to NRT [25]. However, some adolescents will
endorse using any product when a list is presented to
them, e.g. 0.4% said they used a fictitious nicotine "Nic-T"
product [26]. In two surveys in the USA, 2.7% and 4.6%
of school drug counsellors indicated that nicotine patches
and gums were abused by adolescents, but these "NRT
abusers" were mainly smokers who used NRT while
smoking, and only 7% to 16% of these "NRT abusers"
were never smokers [27]. The latter study did not report
any case of NRT dependence in adolescent never smokers
[27]. Similarly, studies in representative samples of the
UK and Swedish general populations found no never-user
of tobacco among users of NRT [28]. A review of post-
marketing surveillance data in the USA found no report of
primary dependence to the nicotine gum and patch,[29]
and only 39 cases of dependence on the nicotine gum
were reported per million prescriptions to smokers, in sur-
veillance data [30]. Therefore, addiction to nicotine gum
in never smokers is probably very rare. Furthermore, there
may be few adverse consequences of being addicted to the
nicotine gum, except for the financial cost and the incon-
venience of permanent chewing. In particular, NRT prod-
ucts are safe even in patients with heart disease, [31,32]
and there was no untoward effect of 5 years of nicotine
gum use in the Lung Health Study [33]. Thus, long-term
use of NRT is not known to be harmful.
Participants volunteered to take part in our study after
finding a link to the questionnaire on Google. This ena-
bled anyone who was looking for information on the nic-
otine gum to find the questionnaire easily. As a result, our
sample consisted of a self-selected group of people who
proactively searched the web for information on the nico-
tine gum, perhaps because they worried about their nico-
tine gum use. This sample is therefore not representative
of all nicotine gum users. In particular, only 2% of USA
households who purchased nicotine gums purchased
them monthly for 6 months or more,[34] and only 6% of
participants in a nicotine gum trial used the gum for 24
weeks or more [35] These figures contrast sharply with the
median duration of 8 months of NRT use in ever smokers
in our survey, which suggests that our method oversam-
pled long-term users of NRT. It is therefore not possible to
extrapolate from our data a population prevalence of
never smokers among daily gum users. Our aim was how-
ever not to determine this prevalence, but to test whether
we could identify any never-user of tobacco or any non-
smoker among nicotine gum users. Our findings haveBMC Public Health 2007, 7:159 http://www.biomedcentral.com/1471-2458/7/159
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important implications for the understanding of the
effects of nicotine, since it was believed until now that nic-
otine addiction could be maintained, but not initiated by
the nicotine gum [5].
Conclusion
Addiction to the nicotine gum in never smokers is proba-
bly quite rare, but this study suggests that it can occur.
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